Fractyl
Dilyafruz Kadirova is an experienced financial professional currently serving as a Financial Reporting Analyst at Oxford Immunotec since April 2016. Responsibilities include EPS calculations, Black-Scholes validation, and various aspects of share-based compensation, along with financial reporting tasks such as 10-K and 10-Q editing and XBRL quarterly reviews. Prior experience includes a role as a Staff Accountant at Calare Properties, Inc., where Dilyafruz prepared financial statements, managed general ledger entries, and oversaw budgeting. Additional accounting experience includes positions at RetroFit Technologies and Mohir-Avto. Dilyafruz holds a Bachelor's degree in Finance from the University of Massachusetts Amherst, as well as education from the Russian University of Chemical Technology and Tashkent University of Information Technology.
This person is not in any teams
Fractyl
2 followers
Fractyl aims to bring curative therapies to the large populations of patients with metabolic disease. With their innovative products, their goal is to truly shift the treatment paradigm for patients with metabolic disease by focusing on their root cause in the intestine to provide meaningful, transformative, benefits to restore patient health from metabolic diseases.